Alvin Shih
CIK 1610064 · EVP of Research & Development · last filed 2025-09-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$253.0K
Companies
2
Total Filings
12
Lifetime Open-Market Net
-$1.54M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ZVRA | Director | 20,000 | $12.65 | $253.0K | $157.8K | 4 | 2025-09-15 |
| Travere Therapeutics, Inc. (RTRX) Delisted | EVP of Research & Development | 158,334 | — | — | -$1.69M | 8 | 2016-09-02 |
Recent Filings · Page 2 of 2
12 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-07-02 | Travere Therapeutics, Inc. (RTRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-06-30 | Travere Therapeutics, Inc. (RTRX) Delisted | Sell (S) | −27,916 | -$912.9K | EDGAR |
Showing 11–12 of 12
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.